ArticleBreast cancer research : BCR2014

Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease.

Aaron J Knox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.